Clinical Trials Directory

Trials / Completed

CompletedNCT02049320

Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI)

Status
Completed
Phase
Study type
Observational
Enrollment
38 (actual)
Sponsor
Joseph D. Tobias · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This is a descriptive retrospective study designed to measure the efficacy of remifentanil sedation and the ability to perform frequent neurological examinations of patients with traumatic brain injuries.

Conditions

Interventions

TypeNameDescription
DRUGRemifentanil

Timeline

Start date
2013-07-01
Primary completion
2016-05-01
Completion
2016-05-01
First posted
2014-01-30
Last updated
2017-02-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02049320. Inclusion in this directory is not an endorsement.

Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI) (NCT02049320) · Clinical Trials Directory